GET REAL RESULTS
Don't just take our word for it. Explore the tangible results we've achieved for our healthcare and HR clients. See the remarkable improvements in outcomes and the significant reduction in workload.
53%
Reduced No-Show Rate
92%
Reduced Post-Op Calls
82%
Readmission Reduction
78%
Enrollment Response Rate
GLP-1 SURGERY CANCELLATIONS AVOIDED THANKS TO TEXTING
Over 1.5 years, 12% of patients, or 2,184 people, self-identified as taking a GLP-1. The timely SMS messages meant their procedures could proceed as planned.
96%
96% OF PATIENTS WERE OPTED-IN TO RECEIVE TEXTS AND WERE SENT THE GLP-1 MESSAGE WORKFLOW
71%
71% OF PATIENTS ANSWERED THE TEXT IN A MEDIAN TIME OF 13 MINUTES
12%
12% OF PATIENTS REPLIED YES AND WERE INSTRUCTED TO STOP THEIR MEDICATION, AVOIDING A 2,184 LAST MINUTE CANCELLATIONS
THE CHALLENGE
GLP-1s like Ozempic and Wegovy are now widely used for managing type-2 diabetes and weight loss. But their popularity has revealed a pre-op risk: delayed gastric emptying. One ASC experienced a rise in same-day surgery cancellations when patients unknowingly stayed on these medications, prompting a revamp of their protocols and patient communication.
THE SOLUTION
The facility’s care team introduced a simple but effective solution using Dialog Health: a text sent 10 days before each procedure asked patients if they were taking a GLP-1 medication. Those who replied YES received clear, timely instructions: stop injectables 7 days before, or orals 24 hours before.
This proactive outreach gave patients the guidance they needed ahead of time, significantly reducing last-minute cancellations, anesthesia risks, and hospital admissions.
THE RESULTS
By identifying potential risks early and delivering clear, timely instructions through Dialog Health the facility improved patient preparedness and protected valuable OR time. With rising GLP-1 usage, proactive communication isn’t just helpful, it’s essential.
TAGS
RELATED CONTENT
